Cargando…
Acquired cancer tyrosine kinase inhibitor resistance: ROS as critical determinants
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709854/ https://www.ncbi.nlm.nih.gov/pubmed/34952897 http://dx.doi.org/10.1038/s41392-021-00844-5 |
| _version_ | 1784623035886600192 |
|---|---|
| author | Bekeschus, Sander |
| author_facet | Bekeschus, Sander |
| author_sort | Bekeschus, Sander |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8709854 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87098542022-01-10 Acquired cancer tyrosine kinase inhibitor resistance: ROS as critical determinants Bekeschus, Sander Signal Transduct Target Ther Research Highlight Nature Publishing Group UK 2021-12-24 /pmc/articles/PMC8709854/ /pubmed/34952897 http://dx.doi.org/10.1038/s41392-021-00844-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Research Highlight Bekeschus, Sander Acquired cancer tyrosine kinase inhibitor resistance: ROS as critical determinants |
| title | Acquired cancer tyrosine kinase inhibitor resistance: ROS as critical determinants |
| title_full | Acquired cancer tyrosine kinase inhibitor resistance: ROS as critical determinants |
| title_fullStr | Acquired cancer tyrosine kinase inhibitor resistance: ROS as critical determinants |
| title_full_unstemmed | Acquired cancer tyrosine kinase inhibitor resistance: ROS as critical determinants |
| title_short | Acquired cancer tyrosine kinase inhibitor resistance: ROS as critical determinants |
| title_sort | acquired cancer tyrosine kinase inhibitor resistance: ros as critical determinants |
| topic | Research Highlight |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709854/ https://www.ncbi.nlm.nih.gov/pubmed/34952897 http://dx.doi.org/10.1038/s41392-021-00844-5 |
| work_keys_str_mv | AT bekeschussander acquiredcancertyrosinekinaseinhibitorresistancerosascriticaldeterminants |